Published in Circulation on April 15, 1996
Mitral valve surgery for mitral regurgitation caused by Libman-Sacks endocarditis: a report of four cases and a systematic review of the literature. J Cardiothorac Surg (2010) 1.18
Mitral valve replacement and repair. Report of 5 patients with systemic lupus erythematosus. Tex Heart Inst J (2001) 1.17
Establishing the diagnosis of Libman-Sacks endocarditis in systemic lupus erythematosus. J Gen Intern Med (2008) 1.02
Neurological dysfunction and hyperactive behavior associated with antiphospholipid antibodies. A mouse model. J Clin Invest (1997) 0.98
Patent foramen ovale, cardiac valve thickening, and antiphospholipid antibodies as risk factors for subsequent vascular events: the PICSS-APASS study. Stroke (2009) 0.86
Double-valve Libman-Sacks endocarditis causing ventricular fibrillation cardiac arrest. Tex Heart Inst J (2011) 0.85
An unusual presentation of lupus in a pediatric patient. Case Rep Pediatr (2013) 0.85
Close association between valvar heart disease and central nervous system manifestations in the antiphospholipid syndrome. Ann Rheum Dis (2005) 0.82
Aggressive cardiac involvement in systemic lupus erythematosus: a case report and a comprehensive literature review. Cardiol Res Pract (2011) 0.81
Severe aortic insufficiency due to a huge leaflet perforation in Libman-Sacks syndrome: report of a case. Surg Today (2011) 0.80
Antiphospholipid syndrome plus rheumatic fever: a higher risk factor for stroke? Rheumatol Int (2011) 0.79
Genomic and physiological responses to strong selective pressure during late organogenesis: few gene expression changes found despite striking morphological differences. BMC Genomics (2013) 0.78
Association of anticardiolipin antibodies with vascular injury: possible mechanisms. Postgrad Med J (2000) 0.78
The antiphospholipid syndrome: from pathophysiology to treatment. Clin Exp Med (2016) 0.77
AA amyloidosis associated with systemic lupus erythematosus: impact on clinical course and outcome. Rheumatol Int (2007) 0.77
Association of antiphospholipid antibodies with valvulopathy in systemic lupus erythematosus: a systematic review. Clin Rheumatol (2011) 0.77
Autoimmune valvular carditis. Curr Allergy Asthma Rep (2015) 0.75
Bentall Surgery in a Patient with Cold Agglutinin and Antiphospholipid Antibody: Double Trouble. J Extra Corpor Technol (2016) 0.75
Lupus-Negative Libman-Sacks Endocarditis Complicated by Catastrophic Antiphospholipid Syndrome. Cardiol Res (2017) 0.75
Embolic Stroke as the Initial Manifestation of Systemic Lupus Erythematosus. Case Rep Rheumatol (2015) 0.75
Mitral valve replacement in systemic lupus erythematosus associated Libman-Sacks endocarditis. J Saudi Heart Assoc (2015) 0.75
Mitral Valve Perforation in Libman-Sacks Endocarditis: A Heart-Wrenching Case of Lupus. J Gen Intern Med (2016) 0.75
Diagnosis and surgical treatment for isolated tricuspid Libman-Sacks endocarditis: a rare case report and literatures review. J Cardiothorac Surg (2015) 0.75
Novel expression of VCAM-1 on the mitral valve in a patient with primary antiphospholipid antibody syndrome. Heart (2000) 0.75
Mitral valvular cyst mimicking a solid mass: misdiagnosis with imaging modalities. Eurasian J Med (2009) 0.75
Heart failure in a woman with SLE, anti-phospholipid syndrome and Fabry's disease. Lupus (2013) 0.75
Mitral valve surgery in patients with systemic lupus erythematosus. ScientificWorldJournal (2014) 0.75
Is it antiphospholipid syndrome? Int J Rheumatol (2011) 0.75
Postpartum culture negative endocarditis: a case report and review of the current guidelines. BMJ Case Rep (2011) 0.75
[Cardiovascular monitoring of patients with systemic lupus erythematosus]. Z Rheumatol (2005) 0.75
Complete Resolution of a Large Bicuspid Aortic Valve Thrombus with Anticoagulation in Primary Antiphospholipid Syndrome. Front Cardiovasc Med (2017) 0.75
A case of catastrophic antiphospholipid syndrome presenting with acute respiratory distress syndrome as the initial manifestation. Rheumatol Int (2008) 0.75
Renal cortical necrosis at presentation in a patient with systemic lupus erythematosus: an autopsy case report. Clin Rheumatol (2010) 0.75
International consensus statement on an update of the classification criteria for definite antiphospholipid syndrome (APS). J Thromb Haemost (2006) 16.11
Prophage induction and cell division in E. coli. III. Mutations sfiA and sfiB restore division in tif and lon strains and permit the expression of mutator properties of tif. Mol Gen Genet (1975) 6.82
Prophage induction and cell division in E. coli. I. Further characterization of the thermosensitive mutation tif-1 whose expression mimics the effect of UV irradiation. Mol Gen Genet (1972) 4.85
Polyspecificity of monoclonal lupus autoantibodies produced by human-human hybridomas. N Engl J Med (1983) 4.43
Assessment of the European classification criteria for Sjögren's syndrome in a series of clinically defined cases: results of a prospective multicentre study. The European Study Group on Diagnostic Criteria for Sjögren's Syndrome. Ann Rheum Dis (1996) 3.68
Catastrophic antiphospholipid syndrome: international consensus statement on classification criteria and treatment guidelines. Lupus (2003) 3.61
[Prophage induction and cell division in E. coli. II. Linked (recA, zab) and unlinked (lex) suppressors of tif-1-mediated induction and filamentation]. Mol Gen Genet (1972) 3.25
Idiotypic cross-reactions of monoclonal human lupus autoantibodies. J Exp Med (1983) 2.96
Rheumatology in Israel. Br J Rheumatol (1996) 2.66
Serum antibodies in epilepsy and seizure-associated disorders. Neurology (2005) 2.53
Inducible sfi dependent division inhibition in Escherichia coli. Mol Gen Genet (1980) 2.50
Tenofovir disoproxil fumarate rescue therapy following failure of both lamivudine and adefovir dipivoxil in chronic hepatitis B. Gut (2010) 2.37
Detection of retroviral antibodies in primary biliary cirrhosis and other idiopathic biliary disorders. Lancet (1998) 2.31
Features of colorectal cancers with high-level microsatellite instability occurring in familial and sporadic settings: parallel pathways of tumorigenesis. Am J Pathol (2001) 2.29
Production of autoantibodies by human-human hybridomas. J Clin Invest (1982) 2.22
Indirect ultraviolet-reactivation of phage lambda. Proc Natl Acad Sci U S A (1974) 2.09
EULAR recommendations for vaccination in adult patients with autoimmune inflammatory rheumatic diseases. Ann Rheum Dis (2010) 2.09
Characterization of biologically active antineutrophil cytoplasmic antibodies induced in mice. Pathogenetic role in experimental vasculitis. Arthritis Rheum (1995) 2.09
Metformin-induced lactic acidosis in the presence of acute renal failure. Diabetologia (1977) 2.08
Anti-DNA antibody idiotypes in systemic lupus erythematosus. Lancet (1984) 2.08
Catastrophic antiphospholipid syndrome: clues to the pathogenesis from a series of 80 patients. Medicine (Baltimore) (2001) 2.02
Further characterization of sfiA and sfiB mutations in Escherichia coli. J Bacteriol (1980) 2.01
The Hippo pathway transcriptional co-activator, YAP, is an ovarian cancer oncogene. Oncogene (2011) 1.95
Induction of a systemic lupus erythematosus-like disease in mice by a common human anti-DNA idiotype. Proc Natl Acad Sci U S A (1988) 1.91
Colchicine treatment for recurrent pericarditis. A decade of experience. Circulation (1998) 1.87
Transforming growth factor beta and the liver. Hepatology (2001) 1.83
Induction of anti-phospholipid syndrome in naive mice with mouse lupus monoclonal and human polyclonal anti-cardiolipin antibodies. Proc Natl Acad Sci U S A (1991) 1.77
Binding of cytoskeletal proteins by monoclonal anti-DNA lupus autoantibodies. Clin Immunol Immunopathol (1984) 1.76
Do guidelines improve the process and outcomes of care in delirium? Age Ageing (2003) 1.74
Anti-Saccharomyces cerevisiae and antineutrophil cytoplasmic antibodies as predictors of inflammatory bowel disease. Gut (2005) 1.73
Which patients with hepatitis C develop liver complications? Hepatology (2000) 1.73
European League Against Rheumatism recommendations for monitoring patients with systemic lupus erythematosus in clinical practice and in observational studies. Ann Rheum Dis (2009) 1.69
Complementary and alternative medicines use by Scottish women with breast cancer. What, why and the potential for drug interactions? Eur J Clin Pharmacol (2011) 1.62
Cognitive assessment in the elderly: a review of clinical methods. QJM (2007) 1.59
Assessment of the reproductive toxicity of a complex mixture of 25 groundwater contaminants in mice and rats. Fundam Appl Toxicol (1995) 1.58
No correlation between prolactin levels and clinical activity in patients with systemic lupus erythematosus. J Rheumatol (1996) 1.58
Cancer and autoimmunity: autoimmune and rheumatic features in patients with malignancies. Ann Rheum Dis (2001) 1.55
Multiple serologic reactions and their relationship to clinical activity in systemic lupus erythematosus. Arthritis Rheum (1984) 1.53
Endothelial dysfunction in young patients with rheumatoid arthritis and low disease activity. Ann Rheum Dis (2004) 1.53
Serum concentrations of 25-OH vitamin D in patients with systemic lupus erythematosus (SLE) are inversely related to disease activity: is it time to routinely supplement patients with SLE with vitamin D? Ann Rheum Dis (2010) 1.52
Targeted gene knockout mediated by triple helix forming oligonucleotides. Nat Genet (1998) 1.51
Immunologic and genetic factors in autoimmune diseases. N Engl J Med (1984) 1.50
Elevated homocysteine levels in patients with Raynaud's syndrome. J Rheumatol (1999) 1.49
The prevalence of coeliac disease antibodies in patients with the antiphospholipid syndrome. Lupus (2003) 1.48
Risk factors for subclinical atherosclerosis in a prospective cohort of patients with systemic lupus erythematosus. Ann Rheum Dis (2003) 1.48
Detection of cross-reactive anti-DNA antibody idiotypes in the serum of systemic lupus erythematosus patients and of their relatives. Arthritis Rheum (1985) 1.48
Anti-serum amyloid component P antibodies in patients with systemic lupus erythematosus correlate with disease activity. Ann Rheum Dis (2005) 1.48
Autoimmune diseases and autoimmunity post-bone marrow transplantation. Bone Marrow Transplant (1998) 1.47
Fetal monitoring in labor. J Natl Med Assoc (1976) 1.46
Decline in pulmonary function during chronic hepatitis C virus therapy with modified interferon alfa and ribavirin. J Viral Hepat (2013) 1.46
Autoantibodies in neoplasia. An unresolved enigma. Cancer (1990) 1.45
Role of beta 2-glycoprotein I in the antiphospholipid antibody binding to endothelial cells. Lupus (1995) 1.44
The role of infection in the pathogenesis of catastrophic antiphospholipid syndrome--molecular mimicry? J Rheumatol (2000) 1.44
Validation of the preliminary criteria for the classification of catastrophic antiphospholipid syndrome. Ann Rheum Dis (2005) 1.44
Transfer of experimental antiphospholipid syndrome by bone marrow cell transplantation. The importance of the T cell. Arthritis Rheum (1995) 1.44
The good, the bad and the ugly of vaccination. Isr Med Assoc J (2000) 1.43
Promoting screening mammography in inner-city settings: a randomized controlled trial of computerized reminders as a component of a program to facilitate mammography. Med Care (1994) 1.43
Overexpression of 15-lipoxygenase in vascular endothelium accelerates early atherosclerosis in LDL receptor-deficient mice. Arterioscler Thromb Vasc Biol (2000) 1.42
Clinical characteristics of ruptured chordae tendineae in hospitalized patients: primary tear versus infective endocarditis. Clin Cardiol (1998) 1.42
Serological Evidence of Coxiella burnetii Infection in Horses in Atlantic Canada. Can Vet J (1987) 1.41
A multidimensional autoantibody analysis specifying systemic lupus erythematosus patients with neuropsychiatric symptomatology. Isr J Med Sci (1992) 1.41
Amplification and overexpression of HER-2/neu in carcinomas of the salivary gland: correlation with poor prognosis. Cancer Res (1994) 1.41
Superior vena cava occlusion in a patient with antiphospholipid antibody syndrome. J Rheumatol (1991) 1.40
Low dose aspirin in patients with ischemic heart disease may precipitate secondary myocardial infarction. Isr J Med Sci (1996) 1.40
Presence of a 16/6 related human anti-DNA common idiotype (SA1) in the anticardiolipin antibodies of patients with primary antiphospholipid syndrome. J Rheumatol (1991) 1.40
Induction of primary antiphospholipid syndrome in mice by immunization with a human monoclonal anticardiolipin antibody (H-3). J Clin Invest (1992) 1.39
Neuroglycopenia and adrenergic responses to hypoglycaemia: insights from a local epidemic of serendipitous massive overdose of glibenclamide. Diabet Med (2009) 1.39
Antiphospholipid antibody testing - slow progress? Int J Clin Pract (2012) 1.39
[Viagra--the first oral treatment for impotence that is not lacking in fatal effects]. Harefuah (1998) 1.38
Prophage induction and cell division in E. coli. V. Dominance and complementation analysis in partial diploids with pleiotropic mutations (tif, recA, zab and lexB) at the recA locus. Mol Gen Genet (1977) 1.38
Effects of exposure to Finnish sauna. Isr J Med Sci (1976) 1.37
Mycobacteria and autoimmunity. Immunol Today (1988) 1.36
Heart involvement in systemic lupus erythematosus, anti-phospholipid syndrome and neonatal lupus. Rheumatology (Oxford) (2006) 1.35
Activities of fluoroquinolones against Streptococcus pneumoniae type II topoisomerases purified as recombinant proteins. Antimicrob Agents Chemother (1999) 1.34
A study of 20 SLE patients with intravenous immunoglobulin--clinical and serologic response. Lupus (1999) 1.31
Estimating sleep parameters: a multitrait--multimethod analysis. J Consult Clin Psychol (1982) 1.29
Morbidity and mortality in the antiphospholipid syndrome during a 5-year period: a multicentre prospective study of 1000 patients. Ann Rheum Dis (2008) 1.28
Hyperimmunization of apo-E-deficient mice with homologous malondialdehyde low-density lipoprotein suppresses early atherogenesis. Atherosclerosis (1998) 1.26
[Indirect induction of prophage lambda by ultraviolet rays]. Mutat Res (1968) 1.25
Possible carriers in erythrocytes. J Cell Physiol (1965) 1.25
The mosaic of autoimmunity. Immunol Today (1989) 1.23
Cloning of the mgtE Mg2+ transporter from Providencia stuartii and the distribution of mgtE in gram-negative and gram-positive bacteria. J Bacteriol (1995) 1.22
Evaluation of the BioPlex 2200 ANA screen: analysis of 510 healthy subjects: incidence of natural/predictive autoantibodies. Ann N Y Acad Sci (2005) 1.22
Complement resistance of human carcinoma cells depends on membrane regulatory proteins, protein kinases and sialic acid. Clin Exp Immunol (2003) 1.22
Enhanced fatty streak formation in C57BL/6J mice by immunization with heat shock protein-65. Arterioscler Thromb Vasc Biol (1999) 1.21
Antiphospholipid antibodies permeabilize and depolarize brain synaptoneurosomes. Lupus (1999) 1.21
Advancing science and technology via 3D culture on basement membrane matrix. J Cell Physiol (2009) 1.20
Sequence-specific endonuclease BamHI: relaxation of sequence recognition. Proc Natl Acad Sci U S A (1982) 1.19
Induction of tissue factor-like activity in monocytes by anti-cardiolipin antibodies. J Immunol (1994) 1.19
Urinary cortisol levels, cellular immunocompetency, and loneliness in psychiatric inpatients. Psychosom Med (1984) 1.18
Systemic lupus erythematosus one disease or many? Autoimmun Rev (2011) 1.18
Gaucher's disease: a disease with chronic stimulation of the immune system. Arch Pathol Lab Med (1982) 1.17
Anti-endothelial cell IgG antibodies from patients with Wegener's granulomatosis bind to human endothelial cells in vitro and induce adhesion molecule expression and cytokine secretion. Arthritis Rheum (1996) 1.17
Detection of antibodies to total histones and their subfractions in systemic lupus erythematosus patients and their asymptomatic relatives. Arthritis Rheum (1987) 1.16
Vitamin D: an instrumental factor in the anti-phospholipid syndrome by inhibition of tissue factor expression. Ann Rheum Dis (2010) 1.15
Ultrasound biomicroscopy of sclerotomy sites after pars plana vitrectomy for diabetic vitreous hemorrhage. Ophthalmology (2000) 1.15